CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 100 filers reported holding CUE BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is 0.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,200 | -49.6% | 4,000 | -20.0% | 0.01% | -44.4% |
| Q2 2023 | $18,250 | +2.2% | 5,000 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $17,850 | -63.2% | 5,000 | -70.6% | 0.01% | -67.9% |
| Q4 2022 | $48,450 | +27.5% | 17,000 | 0.0% | 0.03% | +27.3% |
| Q3 2022 | $38,000 | +26.7% | 17,000 | +41.7% | 0.02% | +15.8% |
| Q2 2022 | $30,000 | +50.0% | 12,000 | +200.0% | 0.02% | +90.0% |
| Q1 2022 | $20,000 | -55.6% | 4,000 | 0.0% | 0.01% | -52.4% |
| Q4 2021 | $45,000 | -22.4% | 4,000 | 0.0% | 0.02% | -41.7% |
| Q3 2021 | $58,000 | +23.4% | 4,000 | 0.0% | 0.04% | +24.1% |
| Q2 2021 | $47,000 | -4.1% | 4,000 | 0.0% | 0.03% | -19.4% |
| Q1 2021 | $49,000 | -2.0% | 4,000 | 0.0% | 0.04% | -12.2% |
| Q4 2020 | $50,000 | -16.7% | 4,000 | 0.0% | 0.04% | -30.5% |
| Q3 2020 | $60,000 | – | 4,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,545,573 | $3,447,000 | 1.85% |
| P.A.W. CAPITAL CORP | 200,000 | $446,000 | 0.67% |
| SANDERS MORRIS HARRIS LLC | 848,048 | $2,020,000 | 0.50% |
| Monaco Asset Management SAM | 458,851 | $1,023,000 | 0.39% |
| Bleichroeder LP | 555,000 | $1,238,000 | 0.26% |
| APOGEM CAPITAL LLC | 110,614 | $247,000 | 0.25% |
| Slate Path Capital LP | 1,483,619 | $3,308,000 | 0.22% |
| Voss Capital, LLC | 200,000 | $446,000 | 0.13% |
| Robertson Stephens Wealth Management, LLC | 478,500 | $1,067,000 | 0.11% |
| CARLSON CAPITAL L P | 535,000 | $1,193,000 | 0.09% |